![Reinhard Gabathuler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Reinhard Gabathuler
Plus aucun poste en cours
Profil
Reinhard Gabathuler is the founder of Synapse Technologies, Inc. Former jobs include Director & Senior VP-Business Development at Nevis Brands, Inc. from 2015 to 2018, Vice President-Brain Research at BioMarin Pharmaceutical, Inc., Principal at the University of British Columbia, Chief Scientific Officer at Angiochem, Inc., Principal at Ludwig Institute for Cancer Research Ltd., and Vice President-Research & Development at biOasis Technologies, Inc. Education includes a doctorate from the University of Lausanne conferred in 1982.
Anciens postes connus de Reinhard Gabathuler
| Sociétés | Poste | Fin |
|---|---|---|
| NEVIS BRANDS INC. | Directeur Général | 08/12/2015 |
| BIOASIS TECHNOLOGIES INC. | Directeur Technique/Scientifique/R&D | 18/09/2017 |
Ludwig Institute for Cancer Research Ltd.
 Ludwig Institute for Cancer Research Ltd. Medical/Nursing ServicesHealth Services Engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials | Corporate Officer/Principal | - |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Synapse Technologies, Inc.
 Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops therapeutic enzymes for blood-brain barrier intravenous injections | Fondateur | - |
Formation de Reinhard Gabathuler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Synapse Technologies, Inc.
Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops therapeutic enzymes for blood-brain barrier intravenous injections | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases | Health Technology |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig Institute for Cancer Research Ltd.
Ludwig Institute for Cancer Research Ltd. Medical/Nursing ServicesHealth Services Engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials | Health Services |
biOasis Technologies, Inc.
 biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
Nevis Brands, Inc.
 Nevis Brands, Inc. BiotechnologyHealth Technology Engages in the research on the field of immunotherapy | Health Technology |
